Accessibility Menu

BioAdaptives

(OTC) BDPT

Current Price$0.00
Market Cap$57.30K
Since IPO (2016)-100%
5 Year-100%
1 Year-91%
1 Month-57%

BioAdaptives Financials at a Glance

Market Cap

$57.30K

Revenue (TTM)

$23.79K

Net Income (TTM)

-$1.47M

EPS (TTM)

-$0.13

P/E Ratio

-0.04

Dividend

$0.00

Beta (Volatility)

0.78 (Low)

Price

$0.00

Volume

367,600

Open

$0.01

Previous Close

$0.00

Daily Range

$0.00 - $0.01

52-Week Range

$0.00 - $0.09

Estimated Earnings Date

N/A

BDPT News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About BioAdaptives

Industry

Personal Products

Employees

1

CEO

James Keener

Headquarters

Las Vegas, NV 89128, US

BDPT Financials

Key Financial Metrics (TTM)

Gross Margin

60%

Operating Margin

-42%

Net Income Margin

-62%

Return on Equity

0%

Return on Capital

46%

Return on Assets

-11%

Earnings Yield

-25.00%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$57.30K

Shares Outstanding

12.01M

Volume

367.60K

Avg. Volume

75.40K

Financials (TTM)

Gross Profit

$12.50K

Operating Income

-$1.04M

EBITDA

-$1.03M

Operating Cash Flow

-$516.03K

Capital Expenditure

-$18.00K

Free Cash Flow

-$534.03K

Cash & ST Invst.

$158.45K

Total Debt

$384.43K

BioAdaptives Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$5.51K

N/A

Gross Profit

$2.61K

N/A

Gross Margin

47.39%

N/A

Market Cap

$57.30K

N/A

Market Cap/Employee

$57.30K

N/A

Employees

1

N/A

Net Income

-$111.09K

+43.6%

EBITDA

-$196.72K

+21.0%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$73.61K

+86.0%

Total Debt

$456.31K

+33.0%

Accounts Receivable

$0.00

-100.0%

Inventory

$42.97K

+5.9%

Long Term Debt

$0.00

N/A

Short Term Debt

$456.31K

+33.0%

Return on Assets

-10.83%

N/A

Return on Invested Capital

46.33%

N/A

Free Cash Flow

-$84.84K

+13.3%

Operating Cash Flow

-$84.84K

+13.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
BSFCBlue Star Foods Corp.
$0.00+0.00%
KOMOFKomo Plant Based Foods Inc.
$0.00+0.00%
QEDNQED Connect, Inc.
$0.00+0.00%
RTONRight On Brands, Inc.
$0.01-45.27%

Trending Stocks

Symbol / CompanyPricePrice Chg
AALAmerican Airlines Group
$14.98+0.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.59+0.04%
TQQQProShares Trust - ProShares UltraPro Qqq
$77.52+0.02%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$40.04-0.02%

Questions About BDPT

What is the current price of BioAdaptives?

BioAdaptives is trading at $0.00 per share.

What is the 52-week range for BioAdaptives?

Over the past 52 weeks, BioAdaptives has traded between $0.00 and $0.09.

How much debt does BioAdaptives have?

As of the most recent reporting period, BioAdaptives reported total debt of $456.31K.

How much cash does BioAdaptives have on hand?

BioAdaptives reported $73.61K in cash and cash equivalents in its most recent financial results.

What is BioAdaptives’s dividend yield?

BioAdaptives does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.